Industry view of targeted therapy combinations in oncology

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination

Networking and collaborating across borders in sub-Saharan Africa

Genomic complexity of metastatic disease and the conundrum of combinations

Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Implications for targeted therapies

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care

Systems medicine approach to optimise drugs and drug combinations for individual AML patients

Work of the WIN consortium and challenges of personalised cancer therapy

Tumour-infiltrating immune cells as classifiers and predictors of outcome

Proactive P4 medicine making blood a window into health and disease

Molecular investigations of immune cells and tumour environment: The ovarian cancer model

Growing tissue stem cells into organoids and tumeroids: Predictive assay development